Compare, Analyse Suven Life Sciences with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFE SCIENCES   MYLAN
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
MYLAN
Dec-18
SUVEN LIFE SCIENCES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3383,498-   
Low Rs1691,925-   
Sales per share (Unadj.) Rs52.11,609.6-  
Earnings per share (Unadj.) Rs6.843.7-  
Cash flow per share (Unadj.) Rs8.6345.1-  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs65.31,741.3-  
Shares outstanding (eoy) m127.28514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.7 288.7%   
Avg P/E ratio x37.162.0 59.8%  
P/CF ratio (eoy) x29.67.9 376.5%  
Price / Book Value ratio x3.91.6 249.4%  
Dividend payout %22.00-   
Avg Mkt Cap Rs m32,2721,395,211 2.3%   
No. of employees `0001.135.0 3.1%   
Total wages/salary Rs m6610-   
Avg. sales/employee Rs Th6,132.223,661.7 25.9%   
Avg. wages/employee Rs Th611.10-   
Avg. net profit/employee Rs Th803.5642.5 125.1%   
INCOME DATA
Net Sales Rs m6,635828,159 0.8%  
Other income Rs m2420-   
Total revenues Rs m6,877828,159 0.8%   
Gross profit Rs m1,604214,297 0.7%  
Depreciation Rs m221155,064 0.1%   
Interest Rs m3839,832 0.1%   
Profit before tax Rs m1,58719,401 8.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718-3,087 -23.3%   
Profit after tax Rs m86922,488 3.9%  
Gross profit margin %24.225.9 93.4%  
Effective tax rate %45.2-15.9 -284.3%   
Net profit margin %13.12.7 482.6%  
BALANCE SHEET DATA
Current assets Rs m6,232462,443 1.3%   
Current liabilities Rs m1,490337,172 0.4%   
Net working cap to sales %71.515.1 472.5%  
Current ratio x4.21.4 304.9%  
Inventory Days Days8684 103.4%  
Debtors Days Days8393 88.5%  
Net fixed assets Rs m4,043160,649 2.5%   
Share capital Rs m127441 28.9%   
"Free" reserves Rs m8,1830-   
Net worth Rs m8,310895,917 0.9%   
Long term debt Rs m18966,981 0.0%   
Total assets Rs m10,3892,403,196 0.4%  
Interest coverage x43.11.5 2,898.7%   
Debt to equity ratio x01.1 0.2%  
Sales to assets ratio x0.60.3 185.3%   
Return on assets %8.72.6 336.7%  
Return on equity %10.52.5 416.8%  
Return on capital %19.53.2 613.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m3,8220-   
CASH FLOW
From Operations Rs m356172,092 0.2%  
From Investments Rs m-279-88,952 0.3%  
From Financial Activity Rs m-225-80,170 0.3%  
Net Cashflow Rs m-1481,426 -10.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.49 Rs / USD

Compare SUVEN LIFE SCIENCES With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SUVEN LIFE SCIENCES With: DR. DATSONS LABS  TORRENT PHARMA  ORCHID PHARMA  WOCKHARDT  BIOCON   



Today's Market

Sensex Trades Marginally Lower, Dow Futures Up by 174 Points(12:30 pm)

Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 29 points, down 0.1% at 48,662 levels.

Related Views On News

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Worst Sector in the Market (Fast Profits Daily)

May 11, 2021

The worst sector in the stock market according to the charts.

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUVEN LIFE SCIENCES SHARE PRICE


May 14, 2021 01:31 PM

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES - ALKEM LABORATORIES COMPARISON

COMPARE SUVEN LIFE SCIENCES WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS